WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2019> 30> 5

Volume: 30 Issue: 5

1. Prognostic value of post-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography in uterine cervical cancer patients treated with radiotherapy: a systematic review and meta-analysis Page:e66—
2. Involved-field radiation therapy for selected cases of recurrent ovarian cancer Page:e67—
3. Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study Page:e70—
4. Prior uterine myoma and risk of ovarian cancer: a population-based case-control study Page:e72—
5. Transperitoneal para-aortic lymphadenectomy by robot assisted laparoscopy in 10 steps Page:e74—
6. Overexpression of HER2/HER3 and clinical feature of ovarian cancer Page:e75—
7. Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling Page:e76—
8. Pseudolaric acid B inhibits PAX2 expression through Wnt signaling and induces BAX expression, therefore promoting apoptosis in HeLa cervical cancer cells Page:e77—
9. The efficacy of modified Swede Colposcopic Index in prediction of high-grade lesion and cancer of cervix Page:e78—
10. Treatment strategies for patients with advanced ovarian cancer undergoing neoadjuvant chemotherapy: interval debulking surgery or additional chemotherapy? Page:e81—
11. Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study Page:e84—
12. PARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progression Page:e86—
13. Preoperative CA-125 in low-grade endometrial cancer: risk stratification and implications for treatment Page:e92—
14. Aromatase inhibition in ovarian cancer: repeated signals of efficacy but tools for patient selection remain elusive Page:e98—
15. Erratum: Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC–IV ovarian cancer Page:e101—
16. Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement Page:e104—
17. How to use immune checkpoint inhibitor in ovarian cancer? Page:e105—
18. Letter to editor in response to: prior uterine myoma and risk of ovarian cancer: a population-based case-control study Page:e106—
19. ASCO 2019 meeting review Page:e107—
20. After the Laparoscopic Approach to Cervical Cancer (LACC) trial: Korean Society of Gynecologic Oncology (KSGO) survey Page:e108—
21. Response to comment on: prior uterine myoma and risk of ovarian cancer: a population-based case-control study Page:e109—

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.